L & S Advisors Inc Intellia Therapeutics, Inc. Transaction History

L & S Advisors Inc

  • $832 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$53.92 - $71.7 $960,423 - $1.28 Million
17,812 New
17,812 $997,000
Q4 2021

Feb 09, 2022
SELL
$100.76 - $138.36 $503,800 - $691,800
-5,000 Closed
0 $0
Q3 2021

Nov 09, 2021
BUY
$132.37 - $176.78 $661,850 - $883,900
5,000 New
5,000 $671,000

Others Institutions Holding NTLA

# of Institutions
314
Shares Held
91.5M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $926M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track L & S Advisors Inc Portfolio

Follow L & S Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of L & S Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on L & S Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email